Cargando…
Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study
OBJECTIVE: The prognosis of patients with relapsed or refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) is poor. Although patients who fail first‐line salvage chemotherapy are candidates for second‐line salvage chemotherapy, the optimal treatment strategy for these patients has not yet been est...
Autores principales: | Yagi, Yu, Kanemasa, Yusuke, Sasaki, Yuki, Sei, Mina, Matsuo, Takuma, Ishimine, Kento, Hayashi, Yudai, Mino, Mano, Ohigashi, An, Morita, Yuka, Tamura, Taichi, Nakamura, Shohei, Okuya, Toshihiro, Shimizuguchi, Takuya, Shingai, Naoki, Toya, Takashi, Shimizu, Hiroaki, Najima, Yuho, Kobayashi, Takeshi, Haraguchi, Kyoko, Doki, Noriko, Okuyama, Yoshiki, Shimoyama, Tatsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523963/ https://www.ncbi.nlm.nih.gov/pubmed/37635630 http://dx.doi.org/10.1002/cam4.6412 |
Ejemplares similares
-
P1153: UTILITY OF THE FRAILTY SCORE FOR PREDICTING PROGNOSIS AND INDIVIDUALIZING TREATMENT INTENSITY IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Yagi, Yu, et al.
Publicado: (2023) -
Hemoglobin‐platelet index as a prognostic factor in patients with peripheral T‐cell lymphoma
por: Yagi, Yu, et al.
Publicado: (2023) -
Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report
por: Yagi, Yu, et al.
Publicado: (2021) -
MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
por: Kageyama, Akihiko, et al.
Publicado: (2021) -
Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
por: Morita, Yuka, et al.
Publicado: (2022)